SAVIMS

SAVIMS logo white
Menu

COVID-19

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Case Report on Encephalitis and Myocarditis Post-COVID-19 Vaccination

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Mörz, M. (2022). A case report: Multifocal necrotizing encephalitis and myocarditis after BNT162b2 mRNA vaccination against COVID-19. Vaccines, 10(10), 1651. https://doi.org/10.3390/vaccines10101651 Summary: This case report details a 76-year-old man with Parkinson’s disease who died three weeks after his third COVID-19 vaccination. Despite a clinical diagnosis of aspiration pneumonia, autopsy revealed unexpected acute vasculitis and […]

COVID-19, Covid-19 vaccines, Other scientific evidence, Treatment, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19 Vaccine Safety Monitoring: FDA Insights

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Treatment, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Anderson, S. (2020). CBER plans for monitoring COVID-19 vaccine safety and effectiveness. Vaccine and Related Biological Products Advisory Committee Meeting Presentation, October 22. FDA. Summary: The FDA’s Vaccines and Related Biological Products Advisory Committee meeting on October 22, 2020, provided insights into the agency’s plans for monitoring the safety and effectiveness of COVID-19 vaccines.

COVID-19, Covid-19 vaccines, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Concerns Over mRNA Vaccine Safety Raised in Open Letter to Health Minister

| | COVID-19, Covid-19 vaccines, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Britz-McKibbin, P., Chaufan, C., Gutschi, L. M., Hardie, J., Mallard, B., Nakatsu, K., Oldfield, P. R., Pelech, S., & Shaw, C. A. (2022). Open letter to the Health Minister regarding Health Canada’s use of the mRNA vaccines. Canadian Covid Care Alliance. Retrieved from www.canadiancovidcarealliance.org Summary: In a letter addressed to Health Minister Jean-Yves Duclos,

COVID-19, Covid-19 vaccines, Ethics, Peer-reviewed evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

Censorship and Suppression of COVID-19 Heterodoxy

| | COVID-19, Covid-19 vaccines, Ethics, Peer-reviewed evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

Reference: Shir-Raz, Y., Elisha, E., Martin, B., Ronel, N., & Guetzkow, J. (2022). Censorship and suppression of COVID-19 heterodoxy: Tactics and counter-tactics. Minerva. https://doi.org/10.1007/s11024-022-09479-4 Summary: This article examines the censorship of dissenting medical views on COVID-19 by various authorities and media. It highlights tactics used against prominent doctors and scientists who challenged mainstream narratives, including

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Insider Revelations on COVID-19 and US Bioweapons Activity

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Classen, J. B. (2022). COVID-19 and illegal US bioweapons activity, an insider’s revelations. Trends in Internal Medicine, 2(2), 1-11. Summary: Dr. Bart Classen’s article discusses his perspective on alleged illegal bioweapons activities tied to COVID-19, primarily implicating the US and Israeli intelligence, specifically Mossad. Classen, who worked at NIAID/NIH from 1988 to 1991, argues

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Addressing Misinformation in COVID-19 Vaccination

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Malhotra, A. (2022). Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine – Part 2. Journal of Insulin Resistance, 5(1), a72. https://doi.org/10.4102/jir.v5i1.72 Summary: Aseem Malhotra’s article critiques the spread of misinformation surrounding COVID-19 mRNA vaccines, highlighting ethical concerns in medical practice and the failure of public health messaging. He argues

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Curing Misinformation about COVID-19 mRNA Vaccines

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Malhotra, A. (2022). Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine – Part 1. Journal of Insulin Resistance, 5(1), a71. https://doi.org/10.4102/jir.v5i1.71 Summary: In this article, Aseem Malhotra critically examines the COVID-19 mRNA vaccines, particularly the Pfizer-BioNTech vaccine, highlighting concerns regarding their safety and effectiveness. Malhotra reflects on his personal

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19 Vaccines: An Australian Perspective on Safety and Efficacy

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Turni, C., & Lefringhausen, A. (2022). COVID-19 vaccines – An Australian review. Journal of Clinical & Experimental Immunology, 7(3), 491-508. Summary: This review examines the safety and efficacy of COVID-19 mRNA vaccines from an Australian viewpoint. It contrasts initial promises made about the vaccines with actual outcomes, highlighting serious side effects including death, based

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Analysis of Serious Adverse Events Following mRNA COVID-19 Vaccination

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomised trials in adults. Vaccine, 40(40), 5798-5805. https://doi.org/10.1016/j.vaccine.2022.08.036 Summary: This article examines serious adverse events (SAEs) associated with mRNA COVID-19 vaccines (Pfizer and Moderna) reported in

Scroll to Top